Pharmaceutical Policy In China-Reference-Cited by-同舟云学术

Pharmaceutical Policy In China

Published:2008-07 Issue:4 Volume:27 Page:1042-1050
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Sun Qiang,Santoro Michael A.,Meng Qingyue,Liu Caitlin,Eggleston Karen¹

Affiliation:

1. Center for Health Management and Policy, Shandong University, in Jinan, People’s Republic of China

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference21 articles.

1. Health service delivery in China: a literature review

2. Who pays for health care in Asia?

3. Who pays for health care in Asia?

4. State Food and Drug Administration South Pharmaceutical Economic Institute, “The Competition of the Top 100 Pharmaceutical Industries Is Challenging” (in Chinese), Medicine Economic News , 10 August 2007 .

5. B. Chen and H. Wang, “China’s Pharmaceutical Industry: Competitive Features, Marketing Conditions, and Development Strategy” (in Chinese), China Pharmacy 13 , no. 5 ( 2002 ): 260 –262.

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the price levels of medical service and influential factors: evidence from China;BMC Public Health;2024-01-08

2. How Government Funding Influences Regional Industrial Innovation Performance: The Role of Openness and Economic Development in Chinese Pharmaceutical Manufacturing Industry;2024

3. Policies and practices in Nigeria’s pharmaceutical sector: A mixed methods exploration of stakeholders’ perspectives on strategic reforms;Health Policy OPEN;2023-12

4. Development and validation of pharmaceutical care barriers scale in Chinese hospitals: a cross-sectional survey;Frontiers in Pharmacology;2023-07-13

5. Medical institutions in the geography of innovation: evidence from public tertiary hospitals and biotech start-ups in Chinese cities;Regional Studies;2023-05-05